Corrected October 2026
What changed and why
This edition was titled "The Supplement Every Statin Patient Should Be Taking" and rated the evidence "High". That isn't supported. Three meta-analyses of CoQ10 for statin muscle symptoms disagree. The largest analysis of statin trials found most muscle symptoms in people taking statins weren't caused by the statin. The page also gave the wrong dose for the Caso trial (it was 100 mg a day, not 600 mg). It reported a blood-pressure figure without the Cochrane review that found no clear effect, and it included a client example. All of that is corrected below. Doses now appear only in the "How much" block.
What changed and why →
Every month in this series I pick one supplement and set out what it does, the human evidence, the forms, who it might suit, and the cautions. No affiliate links. Just the honest picture, including where the evidence is weak.
This month: CoQ10, and the question most people ask about it. If you take a statin, should you take CoQ10 too?
Why statins and CoQ10 are linked
Statins lower cholesterol by blocking an enzyme early in the mevalonate pathway. The same pathway also makes CoQ10, so blocking it lowers the body's own CoQ10 production as well. That much is established biochemistry, and studies consistently find lower blood CoQ10 in people taking statins.
What isn't established is the next step. Lower CoQ10 in the blood hasn't been shown to cause the muscle symptoms some people get on statins, or to harm the heart. That's a plausible idea. Grade: mechanistic. The way to find out is to give CoQ10 to people with statin muscle symptoms and see whether they improve. That has been done, and the results are below.
Statin muscle symptoms: what the trials show
First, how often the statin is the cause. The Cholesterol Treatment Trialists pooled 19 double-blind trials of statin versus placebo in nearly 124,000 people. Muscle pain or weakness was reported by 27.1% of people on a statin and 26.6% on placebo. There was a small excess in the first year, more with high-intensity statins. Overall, more than 90% of muscle complaints in people taking statins weren't caused by the statin (CTT 2022). That doesn't mean symptoms aren't real. It means the statin is often not the reason, and stopping it isn't the only option to consider.
Then, whether CoQ10 helps. Three meta-analyses of randomised trials disagree:
- Kennedy 2020: 7 trials, 321 people. No benefit on muscle pain, and no effect on staying on the statin.
- Qu 2018: 12 trials, 575 people. Less muscle pain, weakness, cramp and tiredness with CoQ10.
- Kovacic 2025: 7 trials, 389 people. A small reduction in pain intensity, with a confidence interval that only just excludes no effect.
All the trials were small and short (30 to 90 days), at doses from 100 to 600 mg a day. One often-quoted trial, Caso 2007, gave 100 mg a day for 30 days to 18 people (against vitamin E in 14), and pain severity fell by 40%. Grade: mixed.
What I now suggest
If muscle symptoms persist on a statin
Talk to your prescriber first. They may check things like thyroid function, vitamin D, creatine kinase and other medicines, or try a different statin or dose. If you both want to try CoQ10, it's worth a time-limited trial with a symptom diary, scoring the pain daily before and during. Stop if nothing has changed by the end of the trial period. Don't stop a statin on your own. I no longer say every statin patient should take it.
Other uses
Heart failure. In Q-SYMBIO, 420 people with moderate to severe heart failure took CoQ10 (100 mg three times a day) or placebo, on top of their usual treatment, for 2 years. Major cardiovascular events were lower with CoQ10 (15% vs 26%), as were cardiovascular and all-cause deaths. The trial's short-term primary endpoints at 16 weeks showed no difference. It is one trial and hasn't been repeated at that size (Mortensen 2014). Grade: one positive trial. If you have heart failure, this is a conversation for your cardiologist, not a self-care decision.
Blood pressure. This page previously said CoQ10 lowers systolic pressure by about 11 mmHg (Rosenfeldt 2007). That analysis was mostly of open-label studies. A Cochrane review, limited to double-blind trials at acceptable risk of bias, found no significant effect on systolic or diastolic pressure (Ho 2016). Grade: no clear effect.
Migraine. In 42 people with migraine, CoQ10 (100 mg three times a day) for three months halved attack frequency in 47.6%, against 14.4% on placebo (Sándor 2005). Grade: one small positive trial.
"Production declines with age." Often said, and a reasonable idea. But taking CoQ10 for general energy in healthy older adults hasn't been tested in trials that show a benefit. Grade: untested.
Forms
CoQ10 is sold as ubiquinone (the oxidised form) or ubiquinol (the reduced form). Most of the trials above used ubiquinone. Ubiquinol is often said to be better absorbed, especially in older adults. That's an absorption claim, not an outcome one: no trial has shown ubiquinol improves symptoms more than ubiquinone. Grade: untested for outcomes. CoQ10 is fat-soluble, so take it with food that contains fat. I've removed the brand I used to name here.
Can a test show whether you need it?
Blood CoQ10 can be measured by some specialist labs, though what level is "too low" in someone on a statin isn't defined. Organic acids markers such as succinate are sometimes read as signs of a mitochondrial bottleneck. Whether they predict who will benefit from CoQ10 hasn't been tested. Grade: untested. I use them as one lead among several, not as a reason to start CoQ10 on their own.
Cautions
- Warfarin: CoQ10 is structurally similar to vitamin K, and there are reports of reduced warfarin effect. If you take warfarin, don't start CoQ10 without your anticoagulation clinic knowing, so your INR can be checked.
- Blood-pressure medicines: the evidence for a BP-lowering effect is weak, but check readings and tell your prescriber.
- Chemotherapy: some oncologists advise against antioxidant supplements during certain treatments. Ask your oncology team.
- Pregnancy: insufficient safety data. Avoid unless your doctor advises it.
For the wider statin question, including who benefits, by how much, and where the critics are right, see LDL, statins and the evidence.
Sources
- Cholesterol Treatment Trialists' Collaboration. Effect of statin therapy on muscle symptoms: an individual participant data meta-analysis of large-scale, randomised, double-blind trials. Lancet 2022;400:832–45. PMID 36049498, doi:10.1016/S0140-6736(22)01545-8
- Kennedy C et al. Effect of coenzyme Q10 on statin-associated myalgia and adherence to statin therapy: a systematic review and meta-analysis. Atherosclerosis 2020;299:1–8. PMID 32179207, doi:10.1016/j.atherosclerosis.2020.03.006
- Qu H et al. Effects of coenzyme Q10 on statin-induced myopathy: an updated meta-analysis of randomized controlled trials. J Am Heart Assoc 2018;7:e009835. PMID 30371340, doi:10.1161/JAHA.118.009835
- Kovacic S et al. Effects of coenzyme Q10 supplementation on myopathy in statin-treated patients: a systematic review and meta-analysis. J Nutr Sci 2025;14:e72. PMID 41158831, doi:10.1017/jns.2025.10043
- Caso G et al. Effect of coenzyme Q10 on myopathic symptoms in patients treated with statins. Am J Cardiol 2007;99:1409–12. PMID 17493470, doi:10.1016/j.amjcard.2006.12.063
- Mortensen SA et al. The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO. JACC Heart Fail 2014;2:641–9. PMID 25282031, doi:10.1016/j.jchf.2014.06.008
- Rosenfeldt FL et al. Coenzyme Q10 in the treatment of hypertension: a meta-analysis of the clinical trials. J Hum Hypertens 2007;21:297–306. PMID 17287847, doi:10.1038/sj.jhh.1002138
- Ho MJ, Li EC, Wright JM. Blood pressure lowering efficacy of coenzyme Q10 for primary hypertension. Cochrane Database Syst Rev 2016;3:CD007435. PMID 26935713, doi:10.1002/14651858.CD007435.pub3
- Sándor PS et al. Efficacy of coenzyme Q10 in migraine prophylaxis: a randomized controlled trial. Neurology 2005;64:713–5. PMID 15728298, doi:10.1212/01.WNL.0000151975.03598.ED
- Hathcock JN, Shao A. Risk assessment for coenzyme Q10 (ubiquinone). Regul Toxicol Pharmacol 2006;45:282–8. PMID 16814438, doi:10.1016/j.yrtph.2006.05.006